BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22136399)

  • 1. Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.
    Moriguchi S; Yabuki Y; Fukunaga K
    J Neurochem; 2012 Feb; 120(4):541-51. PubMed ID: 22136399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice.
    Moriguchi S; Han F; Nakagawasai O; Tadano T; Fukunaga K
    J Neurochem; 2006 Apr; 97(1):22-9. PubMed ID: 16515554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
    Moriguchi S; Yamamoto Y; Ikuno T; Fukunaga K
    J Neurochem; 2011 Jun; 117(5):879-91. PubMed ID: 21434925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
    Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K
    J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
    Moriguchi S; Shioda N; Han F; Narahashi T; Fukunaga K
    J Neurochem; 2008 Aug; 106(3):1092-103. PubMed ID: 18445137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats.
    Yabuki Y; Nakagawasai O; Moriguchi S; Shioda N; Onogi H; Tan-No K; Tadano T; Fukunaga K
    Neuroscience; 2013 Mar; 234():103-15. PubMed ID: 23313709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus.
    Han F; Shioda N; Moriguchi S; Yamamoto Y; Raie AY; Yamaguchi Y; Hino M; Fukunaga K
    J Pharmacol Exp Ther; 2008 Jul; 326(1):127-34. PubMed ID: 18388258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
    Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
    Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
    Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
    J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
    Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K
    Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domoic acid induces a long-lasting enhancement of CA1 field responses and impairs tetanus-induced long-term potentiation in rat hippocampal slices.
    Qiu S; Jebelli AK; Ashe JH; CurrĂ¡s-Collazo MC
    Toxicol Sci; 2009 Sep; 111(1):140-50. PubMed ID: 19564213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
    Yamamoto Y; Shioda N; Han F; Moriguchi S; Nakajima A; Yokosuka A; Mimaki Y; Sashida Y; Yamakuni T; Ohizumi Y; Fukunaga K
    Brain Res; 2009 Oct; 1295():218-29. PubMed ID: 19646972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment.
    Moriguchi S; Tagashira H; Sasaki Y; Yeh JZ; Sakagami H; Narahashi T; Fukunaga K
    J Neurochem; 2014 Mar; 128(6):927-37. PubMed ID: 24164423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Ca(2+)/calmodulin-dependent protein kinase II activity and its relation to performance in passive avoidance response and long-term potentiation formation in mice prenatally exposed to diethylstilbestrol.
    Kaitsuka T; Fukunaga K; Soeda F; Shirasaki T; Miyamoto E; Takahama K
    Neuroscience; 2007 Feb; 144(4):1415-24. PubMed ID: 17184923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of long-term potentiation and CaMKII autophosphorylation in rat cortical slices.
    Moriguchi S; Shioda N; Yamamoto Y; Tagashira H; Fukunaga K
    J Neurochem; 2012 Apr; 121(1):44-53. PubMed ID: 22251222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice.
    Han F; Nakano T; Yamamoto Y; Shioda N; Lu YM; Fukunaga K
    Brain Res; 2009 Apr; 1265():205-14. PubMed ID: 19233146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory consolidation induces N-methyl-D-aspartic acid-receptor- and Ca2+/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties.
    Bevilaqua LR; Medina JH; Izquierdo I; Cammarota M
    Neuroscience; 2005; 136(2):397-403. PubMed ID: 16182449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
    Zhao D; Watson JB; Xie CW
    J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region.
    Moriguchi S; Shioda N; Yamamoto Y; Fukunaga K
    Neuroscience; 2010 Apr; 166(4):1158-66. PubMed ID: 20074623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+/calmodulin-dependent protein kinase II and protein kinase C activities mediate extracellular glucose-regulated hippocampal synaptic efficacy.
    Moriguchi S; Oomura Y; Shioda N; Han F; Hori N; Aou S; Fukunaga K
    Mol Cell Neurosci; 2011 Jan; 46(1):101-7. PubMed ID: 20807573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.